LYEL LYELL IMMUNOPHARMA
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 10 analyst firms say about LYELL IMMUNOPHARMA: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
8 rated views · 10 analyst/firm records · 10 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8078
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8049
Recent analyst activity · last 90 days
Our tracked history has 6 reports on LYEL from 5 analyst firms in the last 90 days (10 firms in the past year).
Comparing each firm's latest target with its previous one: 1 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| B Riley Securities | Yuan Zhi | Buy | 22 Jul 2026 | 44.00 USD |
| Baird | Jack K Allen | Buy | 30 Apr 2026 | 49.00 USD |
| Citigroup | Unnamed analyst | Buy | 14 Aug 2026 | — |
| Citizens JMP | Reni Benjamin | Buy | 15 Jun 2026 | 34.00 USD |
| H.C. Wainwright | Mitchell S. Kapoor | Buy | 11 Sep 2026 | 45.00 USD · 7 Aug 2026 |
| Needham | Gil Blum | Buy | 11 Sep 2026 | 44.00 USD |
| RBC Capital Markets | Unnamed analyst | — | 14 Aug 2026 | 34.00 USD |
| Stifel | Stephen Willey | Buy | 6 Aug 2026 | 36.00 USD |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 18 May 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 07:09 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.